Literature DB >> 4214404

Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.

A Liuzzi, P G Chiodini, L Botalla, F Silvestrini, E E Müller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4214404     DOI： 10.1210/jcem-39-5-871

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  16 in total

1.  Treatment of pituitary tumors: history.

Authors:  Gaya Thanabalasingham; Niki Karavitaki; Simon Cudlip; John A H Wass
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

2.  Endocrinological differentiation of primary hypothalamic and pituitary disease.

Authors:  E E Müller
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

Review 3.  Bromocriptine in the treatment of acromegaly.

Authors:  D E Bateman; W M Tunbridge
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

4.  Long-term treatment of acromegaly with bromocriptine.

Authors:  J A Wass; M O Thorner; D V Morris; L H Rees; A S Mason; A E Jones; G M Besser
Journal:  Br Med J       Date:  1977-04-02

5.  The growth hormone responses to L-dopa and TRH in acromegaly.

Authors:  I Jialal; C Naidoo; B C Nathoo; M C Rajput; S M Joubert
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

6.  Pregnancy in an acromegalic after bromocriptine therapy.

Authors:  C O'Herlihy
Journal:  Ir J Med Sci       Date:  1980-07       Impact factor: 1.568

7.  Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor.

Authors:  D M Cook; M A Greer; H Paxton
Journal:  West J Med       Date:  1987-08

Review 8.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

9.  The effects of oral clonidine on the growth hormone level in acromegalic patients.

Authors:  L Gáspár; T Janáky; Z Valkusz; F A László
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

10.  Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states.

Authors:  G Verde; P G Chiodini; A Liuzzi; R Cozzi; F Favales; L Botalla; B Spelta; D Dalla Bonzana; E Rainer; R Horowski
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.